Repare Therapeutics Announces Board and Executive Changes
| Field | Detail |
|---|---|
| Company | Repare Therapeutics Inc. |
| Form Type | 8-K |
| Filed Date | Dec 19, 2025 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $800, $364,800, $150,000, $194,560, $680,960 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
TL;DR
Repare Therapeutics shakes up its board and executive pay structure.
AI Summary
Repare Therapeutics Inc. announced on December 18, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory plans.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can indicate internal shifts that may affect future performance or strategic direction.
Key Players & Entities
- Repare Therapeutics Inc. (company) — Registrant
- December 18, 2025 (date) — Date of earliest event reported
- 7171 Frederick-Banting, Building 2 Suite 270 (address) — Principal Executive Offices
- St-Laurent, Quebec, Canada (location) — Principal Executive Offices Location
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates the departure of certain officers and directors, but does not specify the exact roles in this summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on December 18, 2025.
What is the principal executive office address for Repare Therapeutics Inc.?
The principal executive office is located at 7171 Frederick-Banting, Building 2 Suite 270, St-Laurent, Quebec, Canada.
What type of compensatory arrangements are mentioned in the filing?
The filing mentions compensatory arrangements of certain officers, but specific details are not provided in this summary.
What is the SIC code for Repare Therapeutics Inc.?
The Standard Industrial Classification (SIC) code for Repare Therapeutics Inc. is 2834, Pharmaceutical Preparations.
Filing Stats: 1,541 words · 6 min read · ~5 pages · Grade level 13.6 · Accepted 2025-12-19 16:14:15
Key Financial Figures
- $800 — ny will pay Dr. Zinda an hourly rate of $800 for the time spent on such services. In
- $364,800 — Benefits "): (i) a lump sum payment of $364,800, less applicable deductions and withhol
- $150,000 — etention payment in the gross amount of $150,000, less applicable deductions and withhol
- $194,560 — (iii) an additional lump sum payment of $194,560, less applicable deductions and withhol
- $680,960 — ion Benefits: (i) a lump sum payment of $680,960, less applicable deductions and withhol
Filing Documents
- d59892d8k.htm (8-K) — 31KB
- 0001193125-25-326871.txt ( ) — 147KB
- rptx-20251218.xsd (EX-101.SCH) — 2KB
- rptx-20251218_lab.xml (EX-101.LAB) — 18KB
- rptx-20251218_pre.xml (EX-101.PRE) — 11KB
- d59892d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. REPARE THERAPEUTICS INC. Date: December 19, 2025 By: /s/ Steve Forte Steve Forte President, Chief Executive Officer and Chief Financial Officer